Breaking News, Financial News

AMRI

Restructuring, Hyaluron acquisition lead to 2Q loss

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 2Q10 2Q Revenues: $49.5 million (-4%) 2Q Loss: $3.9 million (earnings of $179,000 in 2Q09) YTD Revenues: $98.8 million (-6%) YTD Loss: $3.9 million (earnings of $2.1 million in 1H09) Comments: Contract revenues for 2Q10 were $40.7 million (+5%). Discovery Services revenues were flat at $11.5 million, Development/Small Scale Manufacturing revenues were up 1% to $8.2 million, and Large Scale Manufacturing was up 10% to $21 million. For 1H10, contract revenues fell 3% to $79.6...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters